Meeting presentation: International Conference of Influenza and the Resurgence of Severe Acute Respiratory Syndrome held on 28–31 October 2003, in Taipei, Taiwan. Abstract No. Session V-2.
Research Article
An interferon-γ-related cytokine storm in SARS patients†
Article first published online: 15 DEC 2004
DOI: 10.1002/jmv.20255
Copyright © 2004 Wiley-Liss, Inc.
Additional Information
How to Cite
Huang, K.-J., Su, I.-J., Theron, M., Wu, Y.-C., Lai, S.-K., Liu, C.-C. and Lei, H.-Y. (2005), An interferon-γ-related cytokine storm in SARS patients. Journal of Medical Virology, 75: 185–194. doi: 10.1002/jmv.20255
- †
Publication History
- Issue published online: 15 DEC 2004
- Article first published online: 15 DEC 2004
- Manuscript Accepted: 15 OCT 2004
Funded by
- National Science Council, Taiwan (SARS Research Project). Grant Number: NSC92-2751-B006-007
- Abstract
- References
- Cited By
Keywords:
- SARS;
- SARS-CoV;
- cytokine;
- interferon-gamma;
- enterovirus 71;
- pulmonary edema;
- dengue hemorrhagic fever
Abstract
Fourteen cytokines or chemokines were analyzed on 88 RT-PCR-confirmed severe acute respiratory syndrome (SARS) patients. IFN-γ, IL-18, TGF-β, IL-6, IP-10, MCP-1, MIG, and IL-8, but not of TNF-α, IL-2, IL-4, IL-10, IL-13, or TNFRI, were highly elevated in the acute phase sera of Taiwan SARS patients. IFN-γ was significantly higher in the Ab(+) group than in the Ab(−) group. IFN-γ, IL-18, MCP-1, MIG, and IP-10 were already elevated at early days post fever onset. Furthermore, levels of IL-18, IP-10, MIG, and MCP-1 were significantly higher in the death group than in the survival group. For the survival group, IFN-γ and MCP-1 were inversely associated with circulating lymphocytes count and monocytes count, but positively associated with circulating neutrophils count. It is concluded that an interferon-γ-related cytokine storm was induced post SARS coronavirus infection, and this cytokine storm might be involved in the immunopathological damage in SARS patients. J. Med. Virol. 75:185–194, 2005. © 2004 Wiley-Liss, Inc.

1096-9071/asset/JMV_centre.gif?v=1&s=0cfbd8a2692b71d14e1d2a1936e4903513e31ac5)
1096-9071/asset/cover.gif?v=1&s=0dade998bc6232d09bc91c43270b9d2734a6bca3)